Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion type Assertion NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_head.
- NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion description "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_provenance.
- NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion evidence source_evidence_literature NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_provenance.
- NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion SIO_000772 23640996 NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_provenance.
- NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion wasDerivedFrom befree-2016 NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_provenance.
- NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion wasGeneratedBy ECO_0000203 NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_provenance.